801 results
Page 2 of 41
424B2
9fs5bj6u d32h9q
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T/A
EX-99
mkvizr pn2w
12 Feb 24
Third party tender offer statement (amended)
7:34am
8-K
EX-99.1
3k2p8p yvih
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
nah4m y2489rhexr1g
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
0p310ex9bbk fmumunf
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
840qthj iqfvkfoj3x
25 Jan 24
Third party tender offer statement
8:13am
SC TO-C
EX-99.2
0zxfgtrid
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.5
31i02hy
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
smwm3ytp5nm2dx98lcl
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.1
5p5e3sgxiz xh
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.4
lhivu 69kh026uj9m8
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.3
227sw8c8 iy
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
ibuj0
22 Dec 23
Additional proxy materials by non-management
4:36pm
DFAN14A
EX-99.1
dbcvum0c35cu5
22 Dec 23
Additional proxy materials by non-management
4:21pm
DFAN14A
m6ui9gspqj af5
22 Dec 23
Additional proxy materials by non-management
4:21pm
8-K
EX-99.1
8hmshw
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
jangoy1j6fkq
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
424B5
fqe6ki10g0dx78wn8
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
qsot6bpfb1oy0 gc7
30 Oct 23
Prospectus supplement
8:05am